** Shares of drugmaker Alembic Pharma ALEM.NS rise as much
as 4.4% to 1,094 rupees, their highest since Jan. 2021
** Reuters could not immediately verify the reason for the
stock move
** Stock last up 2.3%, on track for third straight session
of gains
** Trading volume 1x the 30-day moving average
** ALEM reported Q3 profit that beat analysts' estimates on
Feb. 5, stock up 11% since then
** Analysts' avg rating on ALEM at "hold"; median PT is
867.50 rupees - LSEG data
** Stock extends YTD gains to 41% after rising ~33% in 2023
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))